Peter Morand is President of Peter Morand & Associates Inc. This Ottawa-based consulting firm undertakes assignments related to governance, business development, technology management and performance measurement with advanced technology companies, universities and other R&D organizations across Canada. He was a member of the International Review Committee that assessed the Alberta Science and Research Authority’s performance for its initial six years of operation. He was also a member of the International Review Committee (2005-06) that assessed the performance of Valorisation Recherche Québec, created in 1999 to accelerate and leverage research and innovation in that province. He served as founding President, CEO and Director of the Canadian Science and Technology Growth Fund Inc. This venture capital fund invested in early-stage advanced technology companies from 1996 until its merger with Growthworks Canadian Fund in 2005.
Morand is also the past President of the Natural Sciences and Engineering Research Council of Canada (NSERC, 1990-95), Canada’s federal agency that currently invests more than $1 billion annually to support university research and training. Before his NSERC appointment, Dr. Morand spent many years at the University of Ottawa as a Professor of Chemistry and occupied Dean of Science and Engineering and Vice Rector’s positions. He is currently a Special Advisor to The Killam Trusts and the Canada Council for the Arts in the adjudication of annual Killam Research Fellowships and Killam Prizes made possible by one of North America’s largest private trusts in support of research and scholarship. In this context, he regularly visits research-intensive universities across Canada and keeps abreast of all disciplines’ latest advances. He chairs the Board of SOVAR, the commercialization arm of ULaval and the Centre Hospitalier de l’Université Laval. He is also a Board member of the Canadian Institute for Photonic Innovations (NCE, based at ULaval) as well as a member of the Advisory Boards of the National Research Council of Canada’s Institute on Biodiagnostic (NRC-IBD) in Winnipeg and of the Institute for Biological Sciences (NRC-IBS) in Ottawa.
Peter Morand has served as a director on the Boards of Adherex Technologies Inc. (TSX-AHX, founding Chair, 1998-2009) and of D-Box Technology Inc. (Longueuil, QC, TSX Venture, DBO-A, 2004-06) and is a past member of the Boards of Variation Biotechnologies Inc. (a vaccine development start-up), of the Ottawa Life Sciences Council (past Chair), of the Canadian Bacterial Diseases Network, of the Institute on Governance, of the Royal Ottawa Health Care Group (mental health), of the Ottawa Hospital and of the Ottawa Health Research Institute. Peter Morand started his career in the pharmaceutical industry at Ayerst Laboratories in Montreal. He obtained his Ph.D. in Organic Chemistry from McGill University and was a postdoctoral fellow with Professor Sir Derek Barton at Imperial College in the U.K. He is the author or co-author of over eighty scientific papers published in Canada, Britain and the U.S. and holds twenty patents. Fluent in English and French, Peter Morand is a frequent speaker and writer on policy and advanced technology issues.
